TY  - JOUR 
AU  - Gupta, Puja
AU  - Han, Shuang-Yin
AU  - Holgado Madruga, Marina
AU  - Mitra, Siddhartha S
AU  - Li, Gordon
AU  - Nitta, Ryan T
AU  - Wong, Albert J
PY  - 2010
UR  - http://hdl.handle.net/10366/170921
AB  - [EN]Background: EGF receptor variant III (EGFRvIII) is the most common variant of the EGF receptor observed in
human tumors. It results from the in frame deletion of exons 2-7 and the generation of a novel glycine residue at the junction of exons 1...
LA  - eng
PB  - SPRINGER NATURE
KW  - EGFRvIII
KW  - Recombinant antibody
KW  - Glioblastoma multiforme
KW  - Tumor-specific antigen
KW  - Immunotherapy
KW  - Diagnostic biomarker
KW  - Single-chain Fv (scFv)
KW  - Immunotherapy
KW  - Glioblastoma
KW  - Single-Chain Antibodies
TI  - Development of an EGFRvIII specific recombinant antibody
DO  - 10.1186/1472-6750-10-72
T2  - BMC Biotechnology
VL  - 10
ER  -